link
Bookmarks
Parvovirus
Janice L. B. Byrne, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
2
0
4

KEY FACTS

  • Terminology

    • Imaging

      • Top Differential Diagnoses

        • Pathology

          • Clinical Issues

            TERMINOLOGY

            • Definitions

              • Erythema infectiosum (fifth disease in children)
              • Major clinical manifestation of fetal infection with parvovirus B19; triad of anemia, heart failure, hydrops
                • Parvovirus B19 infection causal in 8-27% of cases of nonimmune hydrops

            IMAGING

            • General Features

              • Ultrasonographic Findings

                • Imaging Recommendations

                  DIFFERENTIAL DIAGNOSIS

                    PATHOLOGY

                    • General Features

                      CLINICAL ISSUES

                      • Presentation

                        • Demographics

                          • Natural History & Prognosis

                            • Treatment

                              Selected References

                              1. Al Shukri I et al: Increased number of parvovirus B19 infections in southeast Scotland in 2012-2013. Clin Microbiol Infect. 21(2):193-6, 2015
                              2. American College of Obstetricians and Gynecologists: Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol. 125(6):1510-25, 2015
                              3. Chen CC et al: Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report. J Med Case Rep. 9:58, 2015
                              4. Ishikawa A et al: Quantitative analysis of human parvovirus B19 DNA in maternal and fetal serum, and amniotic fluid during an early stage of pregnancy. J Med Virol. 87(4):683-5, 2015
                              5. Kyeong KS et al: Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops. Fetal Pediatr Pathol. 34(1):49-56, 2015
                              6. Li JJ et al: Parvovirus infection: an immunohistochemical study using fetal and placental tissue. Pediatr Dev Pathol. 18(1):30-9, 2015
                              7. Melamed N et al: Fetal thrombocytopenia in pregnancies with fetal human parvovirus-B19 infection. Am J Obstet Gynecol. 212(6):793.e1-8, 2015
                              8. Crane J et al: Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 36(12):1107-16, 2014
                              9. Hichijo A et al: A case of fetal parvovirus b19 myocarditis that caused terminal heart failure. Case Rep Obstet Gynecol. 2014:463571, 2014
                              10. Macé G et al: Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops. Prenat Diagn. 34(11):1023-30, 2014
                              11. Riipinen A et al: Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland. Occup Environ Med. 71(12):836-41, 2014
                              12. Fishman SG et al: Parvovirus-mediated fetal cardiomyopathy with atrioventricular nodal disease. Pediatr Cardiol. 32(1):84-6, 2011
                              13. Enders M et al: Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol. 49(3):163-8, 2010
                              14. Podymow T et al: Pregnancy-associated parvovirus B19 infection causing postinfectious glomerulonephritis. Hypertens Pregnancy. 29(4):429-33, 2010
                              15. Bekhit MT et al: In utero treatment of severe fetal anaemia due to parvovirus B19 in one fetus in a twin pregnancy--a case report and literature review. Fetal Diagn Ther. 25(1):153-7, 2009
                              16. Simms RA et al: Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Fetal Diagn Ther. 25(4):373-8, 2009
                              17. Staroselsky A et al: Exposure to fifth disease in pregnancy. Can Fam Physician. 55(12):1195-8, 2009
                              18. Tolfvenstam T et al: Parvovirus B19 infection. Semin Fetal Neonatal Med. 14(4):218-21, 2009
                              19. de Haan TR et al: Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load. BJOG. 115(1):76-81, 2008
                              20. Pistorius LR et al: Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther. 24(4):491-4, 2008
                              Related Anatomy
                              Loading...
                              Related Differential Diagnoses
                              Loading...
                              References
                              Tables

                              Tables

                              KEY FACTS

                              • Terminology

                                • Imaging

                                  • Top Differential Diagnoses

                                    • Pathology

                                      • Clinical Issues

                                        TERMINOLOGY

                                        • Definitions

                                          • Erythema infectiosum (fifth disease in children)
                                          • Major clinical manifestation of fetal infection with parvovirus B19; triad of anemia, heart failure, hydrops
                                            • Parvovirus B19 infection causal in 8-27% of cases of nonimmune hydrops

                                        IMAGING

                                        • General Features

                                          • Ultrasonographic Findings

                                            • Imaging Recommendations

                                              DIFFERENTIAL DIAGNOSIS

                                                PATHOLOGY

                                                • General Features

                                                  CLINICAL ISSUES

                                                  • Presentation

                                                    • Demographics

                                                      • Natural History & Prognosis

                                                        • Treatment

                                                          Selected References

                                                          1. Al Shukri I et al: Increased number of parvovirus B19 infections in southeast Scotland in 2012-2013. Clin Microbiol Infect. 21(2):193-6, 2015
                                                          2. American College of Obstetricians and Gynecologists: Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol. 125(6):1510-25, 2015
                                                          3. Chen CC et al: Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report. J Med Case Rep. 9:58, 2015
                                                          4. Ishikawa A et al: Quantitative analysis of human parvovirus B19 DNA in maternal and fetal serum, and amniotic fluid during an early stage of pregnancy. J Med Virol. 87(4):683-5, 2015
                                                          5. Kyeong KS et al: Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops. Fetal Pediatr Pathol. 34(1):49-56, 2015
                                                          6. Li JJ et al: Parvovirus infection: an immunohistochemical study using fetal and placental tissue. Pediatr Dev Pathol. 18(1):30-9, 2015
                                                          7. Melamed N et al: Fetal thrombocytopenia in pregnancies with fetal human parvovirus-B19 infection. Am J Obstet Gynecol. 212(6):793.e1-8, 2015
                                                          8. Crane J et al: Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 36(12):1107-16, 2014
                                                          9. Hichijo A et al: A case of fetal parvovirus b19 myocarditis that caused terminal heart failure. Case Rep Obstet Gynecol. 2014:463571, 2014
                                                          10. Macé G et al: Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops. Prenat Diagn. 34(11):1023-30, 2014
                                                          11. Riipinen A et al: Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland. Occup Environ Med. 71(12):836-41, 2014
                                                          12. Fishman SG et al: Parvovirus-mediated fetal cardiomyopathy with atrioventricular nodal disease. Pediatr Cardiol. 32(1):84-6, 2011
                                                          13. Enders M et al: Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol. 49(3):163-8, 2010
                                                          14. Podymow T et al: Pregnancy-associated parvovirus B19 infection causing postinfectious glomerulonephritis. Hypertens Pregnancy. 29(4):429-33, 2010
                                                          15. Bekhit MT et al: In utero treatment of severe fetal anaemia due to parvovirus B19 in one fetus in a twin pregnancy--a case report and literature review. Fetal Diagn Ther. 25(1):153-7, 2009
                                                          16. Simms RA et al: Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Fetal Diagn Ther. 25(4):373-8, 2009
                                                          17. Staroselsky A et al: Exposure to fifth disease in pregnancy. Can Fam Physician. 55(12):1195-8, 2009
                                                          18. Tolfvenstam T et al: Parvovirus B19 infection. Semin Fetal Neonatal Med. 14(4):218-21, 2009
                                                          19. de Haan TR et al: Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load. BJOG. 115(1):76-81, 2008
                                                          20. Pistorius LR et al: Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther. 24(4):491-4, 2008